유백피의 항혈전 활성 분획 및 유효성분에 관한 연구 = Antiplatelet fraction from Ulmi cortex and its active components

다국어 초록 (Multilingual Abstract)

Objectives : The purpose of this study was to identify active fraction and components from antiplatelet Ulmi cortex extract. Methods : The 70% ethanol extract of Ulmi cortex was subjected to column chromatography over D101 resinand eluted with an 20% (W1), 30% (W2), 40% (W3), 50%(W4), 70% (W5), and 100% ethanol (W6) to yield 6 fractions. W6 was further fractioned and its active components were purified using semi-preparative HPLC. The isolated compounds were identified by MS and NMR, and their contents were simultaneously analyzed using HPLC/UV. Antiplatelet aggregation activities of the fractions and the compounds were evaluated using rat platelet-rich plasma in presence of collagen (5 μg/ml), arachidonic acid (0.05 U/ml), or thrombin (100 μM). Results : Among six fractions, W3 prominently inhibited platelet aggregation. At the concentration of 200μg/ml, W3 strongly inhibited arachidonic acid- and collagen-induced platelet aggregations by 78.2% and 65.9%, respectivley, and weakly inhibited thrombin-inducded platelet aggregation by 32.6%. Catechin, epicatehin, and catechin-7-O-β-D-glucopyranoside were isolated from W3 and their contents were revealed to be 15.1%, 0.87%, and 0.32%. Catechin and epicatechin at the concentrations of 100 μM strongly inhibited collagen-induced platelet aggregation by 79.9% and 86.6%, respectively, but weakly inhibited arachidonic acid- and thrombin-induced platelet aggregations. Conclusions : A main active principle of anitplatelet Ulmi Cortex extract is W3 fraction, of which main active component is catechin considering its antiplatelet activity and content.

참고문헌 (Reference)

1 권영민, "왕느릅나무 수피의 페놀성 화합물 및 항산화 활성" 한국생약학회 33 (33): 404-410, 2002

2 Yang GH, "Toxicological studies of antioxidants, butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA)" 14 : 283-288, 1982

3 Pignatelli P, "The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide" 72 : 1150-1155, 2000

4 Yun YP, "The antithrombotic effect effect of green tea catechins" 11 : 77-82, 1996

5 Born GVR, "Quantitative investigations into the aggregation of blood platelets" 162 : 67-68, 1962

6 Sagesaka-Mitane Y, "Platelet aggregation inhibitors in hot water extract of green tea" 38 : 790-793, 1990

7 Lee HS, "How safe is the readministration of streptokinase?" 13 : 76-80, 1995

8 Kim JK, "Extractives from barks of Quercus acutissima and Quercus variabilis" 21 : 41-48, 2002

9 Yang WK, "Extract of Ulmus macrocarpa Hance Prevents Thrombus formation by Antiplatelet Activity" 31 : 2013

10 Kim YW, "Evaluation of thrombolytic effect of streptokinase-dextran conjugate in a rat model of arterial hrombosis" 29 : 211-216, 1999

11 Halliwell B, "Establishing the significance and optimal intake of dietary antioxidants: The biomarker concept" 57 : 104-113, 1999

12 Ce´cile CO, "Catechin and epicatechin deprotonation followed by 13C-NMR" 43 : 4545-4549, 2002

13 Ito N, "Carcinogenicity and odification of the carcinogenic response by BHA, BHT, nd other antioxidants" 15 : 109-150, 1985

14 Zheng W, "Antioxidant activity and phenolic compounds in selected herbs" 49 : 5165-5170, 2001